Under construction – not a live service
Sign in
Taking people in FranceNo phase

Studying walking patterns in people living with multiple sclerosis

Looks at walking patterns in adults with multiple sclerosis, compared with healthy adults.

Plain-language title generated from the registry record
Registry title: Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

Key facts

Where
Lille, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07388992, who can take part

Where in France

  • CHU LilleLille, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
SYSNAV
Trial code
NCT07388992
Record updated
23 March 2026
Original description
The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)Read full original descriptionShow less

Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)

Inclusion: For people living with multiple sclerosis (pwMS):; Age at inclusion between =18 and =65 years old; Signed informed consent and ability to comply with study and follow-up; Confirmed MS diagnosis according to McDonald criteria (2017); Expanded Disability Status Scale EDSS = 6; Stable treatment for 2 months before inclusion (for both disease modifying and symptomatic therapies); Ability and willingness to participate in and comply with all study procedures defined in the protocol; Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category; For Healthy volunteers :; Age at inclusion between =18 and =65 years old; Signed informed consent and ability to comply with study and follow-up; Ability and willingness to participate in and comply with all study procedures defined in the protocol; Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category.

Exclusion: Participants with a relapse within the past 3 months before the inclusion; Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator; Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator; Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator; Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator; For pwMS:; Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent; For healthy volunteers (HV):; Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.

ClinicalTrials.gov NCT07388992